This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.

Learn practical strategies to recognize, monitor, and manage cytokine release syndrome (CRS), neurotoxicity (ICANS), and infection risk associated with bispecific antibody therapy in multiple myeloma, with an emphasis on patient safety and care coordination.

Learn about transitions of care in multiple myeloma, emphasizing the importance of coordinated communication.

Learn about survivorship and self management strategies for multiple myeloma patients

Learn about the use of bispecific treatments in multiple myeloma

An overview of nursing considerations for myeloma patients with renal impairment, including the role of dose modifications

An exciting novel treatment for patients with myeloma 

Using the patient’s own immune system to destroy myeloma cells.

Is treatment working? An overview of myeloma treatment history and management over the course of the disease.

An overview of myeloma treatments: Steroids, IMiDs, and PIs

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.